Smarter Integrated Pain Solutions.

We are looking for innovative and differentiated solutions for effective pain relief and management, spanning OTC medicines, medical devices, food supplements, and healthtech solutions. Both systemic and topical approaches are in scope.​

Solutions may include novel active ingredients, advanced formulations and delivery technologies, medical devices, healthtech solutions, and other differentiated approaches. ​

Solutions may address acute or chronic pain, including:

• back pain, ​

• muscle and joint pain,​

• headache and migraine, ​

• abdominal and belly pain,​

• menstrual pain,​

• osteoarthritis and other inflammatory pain conditions.​

Solutions should demonstrate clinically substantiated benefits, meaningful differentiation versus existing approaches, and an appropriate regulatory pathway with a relevant pain relief-related claim.​

As a big global player in pain relief across multiple markets, we aim to broaden our approach by offering consumers complementary, clinically validated, and easy-to-use solutions for pain relief and management. We are looking for innovations that can improve the overall pain management experience, address unmet consumer needs, and support better quality of life, while meeting high standards for safety, efficacy, usability, and regulatory compliance.​

Must-have Requirements.

• Demonstrated pain-relief or pain-management claims, supported by robust clinical data.
• Strong scientific rationale and a clear mechanism supporting the intended benefit.​
• Appropriate regulatory status or a credible regulatory pathway, depending on the product category and target market (e.g., CE marking under EU MDR for medical devices, applicable FDA pathway in the U.S., or compliant/authorized health-claim positioning for food supplements).​
• Clear and meaningful differentiation versus existing pain care solutions.​

Preferred Requirements. ​

• Fast onset of action for rapid pain relief.​
• Long-lasting effect.​
• Potential to complement existing pain treatments.​
• Improved convenience, usability, or adherence versus current solutions.​
• Proprietary or protected technology with a strong competitive advantage.​

Approaches​ not of interest.

• Generic or me-too solutions with limited differentiation versus existing pain-management options.​
• Early-stage projects lacking robust evidence of efficacy, safety, stability, scalability, and manufacturing readiness.​
• Solutions supported only by preclinical evidence, without relevant clinical validation.​
• Approaches with unclear regulatory feasibility or no credible pathway to a pain relief-related claim.​

Target Group​.

Adults and children, no specific health conditions​

Geographies​.

Global